Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Vivian Mo, MD

    TitleClinical Associate Professor of Medicine (Clinician Educator)
    SchoolKeck School of Medicine of USC
    AddressHCC 322
    Health Sciences Campus
    Los Angeles California 90089-9198
    Phone+1 323 442 6130
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Vivian Mo is an Assistant Professor of Clinical Medicine and specializes in cardiology and echocardiography. She completed her internship and residency in internal medicine and a fellowship in cardiology at the University of Texas - Southwestern Medical Center in Dallas. Currently she is the director of the Women's Cardiovascular Center of USC and is an active medical educator by serving as the associate program director of the cardiovascular medicine fellowship program.

      While at USC, Dr. Mo has continued her research in the fields of preventive cardiology, echocardiography and cardiovascular disease in women. She currently serves as a co-investigator on a study which addresses carotid plaque composition by MRI while on statin therapy. She is also a site principal investigator for the VIRGO study which examines why outcomes of women differ from those of men in acute myocardial infarctions.

      Dr. Mo is a fellow of the American College of Cardiology and the American Society of Echocardiography, and is a member of the American Heart Association.

      Collapse Biography 
      Collapse Awards and Honors
      1995LEXIA Scholarship
      Psi Chi Honor Society1996Excellence in Psychology
      Houston International Fund1996Scholarship
      University of Texas- Southwestern Medical Center2003Nomination for Outstanding Clinical Medicine Resident
      2007Charles S. Houston Award

      Collapse ORNG Applications 
      Collapse Websites
      Collapse Twitter

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Ge RL, Mo V, Januzzi JL, Jin G, Yang Y, Han S, Wood MJ, Levine BD. B-type natriuretic peptide, vascular endothelial growth factor, endothelin-1, and nitric oxide synthase in chronic mountain sickness. Am J Physiol Heart Circ Physiol. 2011 Apr; 300(4):H1427-33. PMID: 21217075.
        View in: PubMed
      2. Kollipara UK, Mo V, Toto KH, Nelson LL, Schneider RA, Neily JB, Drazner MH. High-sodium food choices by southern, urban African Americans with heart failure. J Card Fail. 2006 Mar; 12(2):144-8. PMID: 16520264.
        View in: PubMed
      3. Mo V, de Lemos JA. The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease. Future Cardiol. 2005 Sep; 1(5):649-56. PMID: 19804105.
        View in: PubMed
      4. Mo V, De Lemos JA. Individualizing therapy in acute coronary syndromes: using a multiple biomarker approach for diagnosis, risk stratification, and guidance of therapy. Curr Cardiol Rep. 2004 Jul; 6(4):273-8. PMID: 15182604.
        View in: PubMed
      5. Greenberg JS, El Naggar AK, Mo V, Roberts D, Myers JN. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer. 2003 Aug 01; 98(3):508-15. PMID: 12879467.
        View in: PubMed
      6. Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, El Naggar AK, Myers JN. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer. 2003 Mar 15; 97(6):1464-70. PMID: 12627511.
        View in: PubMed
      7. Myers JN, Greenberg JS, Mo V, Roberts D. Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 2001 Dec 15; 92(12):3030-6. PMID: 11753980.
        View in: PubMed